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The transfer of an inflammatory message across the blood-brain barrier (BBB) is important in a range of biological responses to ongoing systemic infection or inflammation in both health and disease. It occurs by means of three main mechanisms:
(1) direct entry of circulating inflammatory molecules or cells [2, 8] , (2) signalling via vagal or somatic sensory afferent projections [11] , and (3) a cascade of cellular activation starting at the immune-brain interface which progressively penetrates deeper layers of the brain parenchyma. Such a biphasic or multiphasic process has been described at three anatomical areas representing the immune-brain interface: cerebral blood vessels, meninges and circumventricular organs [3, 17, 20, 27] , and is evidenced by a delayed and distinct cytokine transcriptional programme [21] .
Over the past few years various groups have demonstrated a key role of cerebral endothelial cells in "sensing" the circulating inflammatory milieu, upregulating cyclooxygenase 2 (COX2), and triggering the chain of events resulting in activation of brain parenchyma [5, 9, 23, 26, 28, 30, 34] , presumably via prostanglandin E2 (PGE2) synthesis. We wanted to examine the role of CD163-positive macrophages in this process. These cells lie abluminal to the cerebral endothelium, or in the meninges itself, and are constitutively activated [13] . CD163-positive macrophages have been shown to upregulate COX2 during systemic inflammatory challenge [10, 28, 30] . In some studies intravenously administered material was endocytosed by these cells, suggesting that they have access to the circulating milieu [4, 22] . In other studies COX2 upregulation occurred in CD163-positive macrophages, but not endothelial cells, after administration of low doses of endotoxin [10, 30] . These studies raised the possibility that CD163-positive macrophages might participate in immune-to-brain signalling either by directly sampling the circulation, or by acting as amplifiers of the endothelial response. Ultimately cytokines in the brain parenchyma are synthesized by glia and neurons, the major source being microglia [29] .
We therefore set out to directly interrogate the role of CD163-positive macrophages by selectively depleting them from a specific region within the forebrain of rats. In all experiments, lipopolysaccharide (LPS E. coli 0111:B4, Sigma, Poole, UK) was administered to model systemic inflammation and de novo cytokine transcription in the right frontal cortex was studied.
Adult male Wistar rats (Harlan, UK) were used in this study under Home Office
Licence and in accordance with the Animals (Scientific Procedures) Act 1986, UK. A radio-telemetry system (Data Sciences International, USA) was used to remotely monitor core body temperature of rats two weeks after intraperitoneal implantation of thermistors.
ICV injections were performed using a minimally invasive stereotaxic procedure causing mild and transient inflammation [1] . Animal perfusion, tissue processing, semiquantitative real-time polymerase chain reaction (RT-PCR) (Applied Biosystems, UK), enzyme-linked immunosorbent assay (ELISA) (R&D Systems, UK), immunohistochemistry/flourescence (ED1 or ED2, 1:200, Serotec, UK), microscopy and quantification were performed as described previously [15, 16] . Statistical analysis was performed in SPSS v12.
To deplete cerebral CD163-positive macrophages, clodronate (a gift of Roche Diagnostics GmbH, Mannheim, Germany) or phosphate-buffered saline (PBS)-loaded liposomes were prepared as described before [31] . Progressive phagocytosis of liposomes by CD163-positive macrophages leads to a lethal rise in intracellular clodronate concentration and consequent apoptosis [32] . 50μl clodronate or PBS-containing liposomes were infused into the 4th ventricle (coordinates: bregma -11.6mm, lateral 0, depth 8.2mm) over 25min. This resulted in selective and complete depletion of cerebral CD163-positive macrophages between days 2 and 10 ( Fig. 2A-D) , as previously reported [25] . We wanted to ensure that this technique did not affect peripheral macrophages.
Although there was no reduction in the density of hepatic and splenic red pulp macrophages in the second week after the ICV infusion (Fig. 2E) , the morphology of a significant proportion of these cells in the clodronate liposome treated animals led us to suspect that they might not be functionally normal, and we wondered whether the ICVinfused liposomes might be draining to the periphery. A direct communication is known to exist between the subarachnoid space and the peripheral circulation through the cribriform plate, nasal lymphatics, deep cervical lymph nodes and thence into the blood [19, 33] . Indeed, ICV infusion of DiI-labelled liposomes revealed their drainage to cervical lymph nodes ( 2I,J). We therefore used ELISA to measure the serum cytokine response after systemic endotoxin challenge (200μg/kg lipopolysaccharide intraperitoneally) on day 9 after ICV liposome infusion. We found that serum levels of TNFα, IL1β and IL6 were significantly lower in clodronate versus control liposome treated animals and a dose-response effect was seen (Fig. 3A) . Lower doses of clodronate liposomes did not affect the serum cytokine response to systemic endotoxin challenge but this was accompanied by unacceptably low CD163-positive macrophage depletion (Fig. 3B) . Several attempts at technique modification were therefore undertaken. It was found that infusion of 15μl concentrated suspension of clodronate-loaded liposomes, diluted to 25μl, in the right lateral ventricle (coordinates: bregma -0.8mm, lateral 1.4mm, depth 4.4mm) of rats over 12.5 minutes did not affect the serum cytokine response to systemic endotoxin challenge on day 9 after the infusion, as compared to control liposomes (Fig. 3C ). This optimized technique resulted in a 65% depletion of CD163-positive macrophages in the septum, 1.8mm rostral to the infusion site, but a more focal almost complete depletion in the right frontoparietal cortex and striatum (98% and 95% respectively, n=5 for both control and clodronate liposome groups). All meningeal CD163-positive macrophages throughout the brain were depleted. This protocol was used in all subsequent experiments, during which we limited analysis of brain cytokine induction to the right frontoparietal cortex, which also had the advantage of avoiding brain regions which are known to be activated directly or indirectly by vagal projections from the periphery during systemic inflammatory challenge [11] .
In order to study immune-to-brain signalling, we administered endotoxin to induce an episode of systemic inflammation. Intravenous injection of 500μg/kg LPS was used in order to achieve less variable and clear-cut central cytokine and fever responses.
Rat cage activity decreased and animals exhibited a hunched posture, piloerection and rigors. Hyperthermia was seen in saline-pretreated animals 2½ hours after endotoxin challenge. Indomethacin pre-treatment (15mg/kg i.p.) 30 minutes prior to systemic endotoxin challenge resulted in complete suppression of this fever when compared to vehicle (Fig. 1A) . Indomethacin administration also resulted in a mild hypothermia; this phenomenon has been previously reported [14] .
8 Systemic inflammation is accompanied by a delayed de novo expression of cytokines behind the BBB [21] . Indeed when intact animals were challenged systemically with endotoxin, we observed significant transcription of TNFα, IL1β and IL6 mRNA in the frontal cortex using RT-PCR; none occurred in animals receiving vehicle (Fig. 1B) .
To determine whether this was PGE 2 -dependent we examined the cerebral cytokine response in animals pre-treated with indomethacin (15mg/kg) or vehicle. This represents a high dose of indomethacin and is sufficient to result in complete suppression of fever (see above) and inducible PGE 2 synthesis [12] . Surprisingly, we observed that indomethacin did not affect the de novo transcription of IL1β seen in the brain after systemic endotoxin challenge in this model (Fig. 1C) ; TNFα and IL6 transcription was not suppressed though a non-significant decrease was observed. These results indicated that a significant amount of cytokine induction behind the BBB in response to systemic inflammation was prostaglandin-independent.
The prevention of hyperthermia as a consequence of pre-treatment with indomethacin prior to the endotoxin challenge suggested that a sufficient amount of the drug was absorbed and available to the immune-brain interface. However de novo brain cytokine induction still occurred after systemic endotoxin challenge in the indomethacin treated animals. Yet, a functional role for cells at the BBB has been inferred on the basis of COX2 and microsomal PGE 2 -synthase expression [5, 9, 23, 26, 28, 30, 34] . We therefore set out to use a different and more direct method to investigate the role of CD163-positive macrophages in immune-to-brain signalling by selectively depleting this population and studying the effect of this depletion on the induction of cerebral cytokine synthesis in response to peripheral inflammation.
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It was first established that ICV infusion of control liposomes per se did not affect the central cytokine response to systemic endotoxin challenge (Fig. 4A) . Then, animals received a clodronate or control liposome ICV infusion, and 9 days later were challenged with endotoxin systemically. Both groups of animals exhibited similar clinical symptoms of endotoxaemia, as described above. No significant differences in TNFα, IL1β and IL6 mRNA levels in the frontoparietal cortex were detected between clodronate and control liposome treated animals (Fig. 4B) . This shows that cerebral CD163-positive macrophages do not have an essential role in the induction of cytokine synthesis within the CNS during systemic inflammation. Cytokine mRNA upregulation may occur in the absence of protein synthesis. We therefore measured IL1β protein by ELISA in the right frontoparietal cortex of endotoxin-challenged animals 9 days after ICV clodronate or control liposome infusion. This confirmed that message was being translated into protein; no significant difference in IL1β protein was observed between clodronate and control liposome treated animals (Fig. 4C) .
The aim of the current study was to determine whether CD163-positive macrophages at the BBB have an essential role in the relay process of an inflammatory stimulus between the periphery and the CNS. In order to do this we carried out a functional study in which we determined the impact of depleting CD163-positive macrophages on cytokine induction within the brain during systemic inflammation.
Regionally specific depletion was achieved by using an ICV infusion of clodronateloaded liposomes. We show that the brain cytokine response to systemic inflammation occurred despite depletion of CD163-positive macrophages. We conclude that CD163-positive macrophages are not essential for immune-to-brain signalling in the healthy brain.
Excluding a role, as compared to proving it, is always difficult. It is of course still possible that a major signalling role of CD163-positive macrophages was taken over by endothelial cells after depletion, or that the very small population of CD163-positive perivascular macrophages (2%) still present after depletion might have been enough to play a signalling role. Circumstantial evidence suggests that this is unlikely. For instance, the early CNS inflammatory response was significantly reduced in bone marrow chimeras three months after transfer of wild-type bone marrow into toll-like receptor 4 knockout mice, at which stage such mice would be expected to have LPS-responsive cerebral CD163-positive macrophages but LPS-resistant endothelial cells [6] . In addition we estimate that the density of CD163-positive macrophages in rat brain is 25 fever [11] , hyperalgesia [18] , activation of the HPA axis [24] and social interaction [7] .
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All these responses can be inhibited by NSAIDs. Here we unearth a clear disparity by showing that de novo cytokine expression within the brain after systemic endotoxin challenge is prostaglandin-independent. The experiments presented here therefore examine a prostaglandin-independent immune-to-brain pathway distinct from that subserved by the circumventricular organs and hypothalamus, which constitute an important immune-brain interface driving the prostaglandin-dependent responses mentioned above.
Finally, this study examines immune-brain signalling in the healthy brain, but CD163-positive macrophages accumulate in response to pathology within the brain [16] and their role in immune-to-brain signalling in the diseased brain remains to be determined. 
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